Skip to search formSkip to main contentSkip to account menu

Gadoxetic acid

Known as: Dihydrogen (N((2s)-2-(bis(carboxymethyl)amino)-3-(p-ethoxyphenyl)propyl)-N-(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))gadolinate(2-) 
National Institutes of Health

Related topics

Related topics

3 relations
Gadoxetate Disodiumgadolinium ethoxybenzyl DTPA

Broader (1)

gadoxetate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Management of subcentimetre arterially enhancing and hepatobiliary hypointense lesions on gadoxetic acid-enhanced MRI in patients at risk for HCC
AbstractObjectivesTo investigate the significance of subcentimetre (≤1 cm) arterially enhancing and hepatobiliary hypointense… 
Review
2016
Review
2016
Hepatic Arterial Phase in Gadoxetic Acid–Enhanced Liver Magnetic Resonance Imaging: Analysis of Respiratory Patterns and Their Effect on Image Quality
ObjectiveThe aims of this study were to objectively evaluate patient respiration and breathing change after contrast injection… 
Review
2014
Review
2014
Focal Lesions in the Cirrhotic Liver: Their Pivotal Role in Gadoxetic Acid-Enhanced MRI and Recognition by the Western Guidelines
Hepatocellular carcinoma (HCC) is a major health concern, and early HCC diagnosis is a primary radiological concern. The goal of… 
Review
2013
Review
2013
Focal nodular hyperplasia: characterisation at gadoxetic acid-enhanced MRI and diffusion-weighted MRI.
PURPOSE The aim of this study was to assess the enhancement patterns of hepatic focal nodular hyperplasia (FNH) on gadoxetic acid… 
Highly Cited
2012
Highly Cited
2012
Attenuation-Based Automatic Kilovolt Selection in Abdominal Computed Tomography: Effects on Radiation Exposure and Image Quality
ObjectivesDose reduction has become a major issue in computed tomography (CT). The benefit of kilovolt (kV) reduction has been… 
2012
2012
Percutaneous computed tomography-guided high-dose-rate brachytherapy ablation of breast cancer liver metastases: initial experience with 80 lesions.
2012
2012
Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist®)-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single…
PurposeTo compare the relative diagnostic performance of MDCT, PET/CT and Primovist-enhanced MRI (P-MRI) in the pre-resection… 
2011
2011
Evaluation of possible drug–drug interaction between gadoxetic acid and erythromycin as an inhibitor of organic anion transporting peptides (OATP)
To evaluate if erythromycin compromises liver‐specific enhancement of gadoxetic acid; both compounds competing in organic anion… 
Highly Cited
2010
Highly Cited
2010
Enhancement of liver parenchyma after injection of hepatocyte‐specific MRI contrast media: A comparison of gadoxetic acid and gadobenate dimeglumine
To compare enhancement of liver parenchyma in MR imaging after injection of hepatocyte‐specific contrast media. 
2008
2008
MRI of hepatic adenomatosis: initial observations with gadoxetic acid contrast agent in three patients.
OBJECTIVE The purpose of our study was to describe the MR signal characteristics of histologically proven liver adenomatosis in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)